clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases

A Real-world Study of Inetetamab for First-line Treatment of MBC

NCT05980208 ·Status: NOT_YET_RECRUITING

UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases

NCT05535413 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug As a Radiosensitizer in Patients with Advanced Breast Cancer Brain Metastasis.

NCT06839547 ·Status: NOT_YET_RECRUITING

Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab in Breast Cancer With Leptomeningeal Metastasis

NCT07263425 ·Status: RECRUITING ·Phase: PHASE2

Study on Bisphosphonates Targeting Triple-negative Breast Cancer

NCT04045522 ·Status: UNKNOWN

High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast Cancer

NCT00584428 ·Status: COMPLETED ·Phase: NA

Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis

NCT06230055 ·Status: RECRUITING ·Phase: PHASE4

Real World Study of Lapatinib Among Metastatic Breast Cancer Patients

NCT03894410 ·Status: COMPLETED

Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer

NCT03204734 ·Status: UNKNOWN ·Phase: PHASE2

Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast Cancer

NCT01924078 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer

NCT02253459 ·Status: COMPLETED ·Phase: PHASE3

A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC

NCT06598046 ·Status: RECRUITING ·Phase: PHASE2

Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients

NCT01395056 ·Status: COMPLETED

Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast Cancer

NCT01526499 ·Status: UNKNOWN ·Phase: PHASE2

Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy

NCT04258163 ·Status: COMPLETED

Treatment With Pyrotinib-Based Therapy in Lapatinib Resistant HER2-Positive Metastatic Breast Cancer

NCT04899128 ·Status: UNKNOWN

Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer

NCT05172518 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer

NCT07019337 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases

NCT07134153 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)

NCT01655992 ·Status: TERMINATED ·Phase: PHASE3

Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer

NCT05063136 ·Status: RECRUITING ·Phase: PHASE3

Pyrotinib Combined With Capecitabine in HER-2 Positive Advanced Breast Cancer and Brain Metastases (Post-PERMEATE)

NCT05359120 ·Status: UNKNOWN

A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer

NCT00568022 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Methotrexate in Breast Cancer With Leptomeningeal Metastasis

NCT06543992 ·Status: RECRUITING ·Phase: PHASE2

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.

NCT00478270 ·Status: WITHDRAWN ·Phase: PHASE2